Mediator



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 24.1%
Diabetes Mellitus 14.7%
Drug Use For Unknown Indication 12.2%
Type 2 Diabetes Mellitus 10.0%
Hypertension 9.9%
Narcolepsy 5.2%
Depression 4.6%
Bipolar Disorder 3.1%
Overweight 2.6%
Hypercholesterolaemia 1.6%
Tremor 1.6%
Depressive Symptom 1.4%
Dyslipidaemia 1.4%
Hyperlipidaemia 1.4%
Systemic Lupus Erythematosus 1.4%
Ill-defined Disorder 1.1%
Migraine 1.0%
Hypothyroidism 0.9%
Weight Control 0.9%
Central Obesity 0.8%
Pulmonary Arterial Hypertension 18.8%
Tricuspid Valve Disease 11.7%
Aortic Valve Incompetence 10.4%
Tricuspid Valve Incompetence 8.4%
Aortic Valve Disease 7.8%
Cardiac Valve Disease 5.8%
Dyspnoea Exertional 4.5%
Mitral Valve Incompetence 4.5%
Pancreatitis Acute 4.5%
Dyspnoea 3.2%
Hepatic Cirrhosis 3.2%
Ventricular Hypokinesia 2.6%
Hypoglycaemia 1.9%
Hypothermia 1.9%
Interstitial Lung Disease 1.9%
Portal Hypertension 1.9%
Pulmonary Hypertension 1.9%
Rash Scarlatiniform 1.9%
Asthenia 1.3%
Bradycardia 1.3%
Concomitant
Drug Use For Unknown Indication 29.7%
Hypertension 11.0%
Depression 7.7%
Rheumatoid Arthritis 7.7%
Diabetes Mellitus 4.9%
Hypercholesterolaemia 4.9%
Overweight 4.1%
Type 2 Diabetes Mellitus 3.8%
Osteoporosis 3.3%
Dyslipidaemia 2.8%
Ill-defined Disorder 2.6%
Insomnia 2.6%
Pain 2.6%
Product Used For Unknown Indication 2.6%
Hyperlipidaemia 2.0%
Ischaemic Cardiomyopathy 2.0%
Diabetes Mellitus Non-insulin-dependent 1.5%
Myalgia 1.5%
Weight Control 1.5%
Hypertriglyceridaemia 1.3%
Metastatic Neoplasm 13.0%
Malaise 9.1%
Aortic Valve Incompetence 6.5%
Tricuspid Valve Incompetence 6.5%
Weight Increased 5.2%
White Blood Cell Count Increased 5.2%
Acute Generalised Exanthematous Pustulosis 3.9%
Atrial Fibrillation 3.9%
Congestive Cardiomyopathy 3.9%
Dyspnoea 3.9%
Mental Disorder 3.9%
Mitral Valve Incompetence 3.9%
Pancreatitis Acute 3.9%
Pancreatitis Necrotising 3.9%
Renal Impairment 3.9%
Rhabdomyolysis 3.9%
Somnolence 3.9%
Thrombocytopenia 3.9%
Transient Ischaemic Attack 3.9%
Vomiting 3.9%